LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

LEMTRADA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Since treatment with LEMTRADA can increase your risk of getting certain conditions and diseases, LEMTRADA is generally prescribed for people who have tried 2 or more MS medicines that have not worked well enough. LEMTRADA is not recommended for use in patients with clinically isolated syndrome (CIS). It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

After Treatment

WHAT TO DO FOLLOWING YOUR LEMTRADA INFUSIONS

Be sure to follow any post-infusion instructions from your healthcare team, which may include:

  • Washing hands frequently to reduce risk of infections
  • Staying hydrated
  • Resting
  • Eating regularly

Eat safely to avoid listeria

People who are about to begin or have recently started treatment with LEMTRADA can be more vulnerable to a serious infection caused by listeria, called listeriosis. Listeria infections have occurred as early as 3 days after treatment and up to 8 months after the last LEMTRADA dose.

Read these food safety tips to help you lower the risk of listeria infection.

Begin your monthly monitoring

Certain side effects of LEMTRADA can happen months and even years after treatment. That’s why it is important to begin monitoring after your first infusion and continue regular monitoring until 4 years after your last infusion. Monitoring can help your healthcare team find potential side effects early.

Post-infusion monitoring includes monthly blood and urine tests

Monthly blood and
urine tests

Post-infusion monitoring includes ongoing symptom self-checks

Ongoing symptom
self-checks

Post-infusion monitoring includes yearly skin exams

Yearly skin exams

It’s very important to have your blood and urine tested even if you’re feeling well and do not have any symptoms from LEMTRADA and relapsing MS.

Your lab monitoring options

Lab monitoring options include any LabCorp or Quest Diagnostics patient service center

LAB

Testing at any LabCorp® or Quest Diagnostics™ patient service centers.

Lab monitoring options include your healthcare provider's office

Healthcare provider’s office

Samples can be taken at your healthcare provider’s office. With this option, you may incur a co-pay for your doctor’s visit. However, the cost of analyzing the samples will be covered by the LEMTRADA Central Lab Program.

Trademarks not owned by Genzyme Corporation or Sanofi are the property of their respective owners.

Identify symptoms with self-checks

Another part of your monitoring routine is to examine yourself for any physical changes. You should perform regular body checks at home by yourself in a mirror, or with the help of a family member or friend. Use the chart below to help you know what to look for.

EYES, NOSE, AND MOUTH

  • Yellowing of the whites of your eyes
  • Eye issues including swelling and/or vision problems
  • Bleeding from gums or nose that is new or takes longer than usual to stop
  • Swelling in your mouth or throat
  • Drooping of parts of your face

RESPIRATORY AND THROAT

  • Cough that is not caused by a cold
  • Coughing up blood
  • Trouble swallowing or breathing
  • Hoarseness or other voice changes that don’t go away
  • Swelling in your throat
  • Wheezing
  • Shortness of breath

PAIN

  • Neck pain
  • Chest pain or tightness
  • Sudden severe headache
  • Stomach pain or discomfort

BOWEL AND URINARY ISSUES

  • Constipation
  • Blood in the urine (red or tea-colored)
  • Decrease in urine
  • Dark urine

SKIN

  • Easy bruising
  • Small, scattered spots that are red, pink, or purple
  • Yellowing of the skin
  • Bleeding from a cut that is hard to stop
  • Swelling in your legs or feet
  • Swelling in your neck
  • New lump
  • Rash

OTHER

  • Fast, slow, or irregular heartbeat
  • Excessive sweating or feeling cold
  • Weakness
  • Worsening tiredness
  • Nervousness
  • Unexplained weight loss or gain
  • Loss of appetite
  • Fever
  • Swollen glands
  • For women: heavier menstrual periods than normal
  • Nausea or vomiting
  • Weakness on one side
  • Difficulty with speech
  • Fatigue

Contact your healthcare team if you experience any of these symptoms, or new or worsening medical problems that have lasted several days, including changes in energy or mood, problems with thinking and/or balance. Read more about making monitoring part of your routine.

The step by step guide to getting started on LEMTRADA treatment

THE STEP BY STEP GUIDE
TO LEMTRADA

Learn what to do before, during, and after treatment. Download now.

Kimberly
LEMTRADA
PATIENT

See why it’s
crucial to

Know what
to expect.

You can learn from Kimberly’s post-infusion fatigue experience.

Important Safety Information See More

LEMTRADA can cause serious side effects including serious autoimmune problems. Some people receiving LEMTRADA develop a condition where the immune cells in your body attack other cells or organs in the body (autoimmunity), which can be serious and may cause death. Serious autoimmune problems may include: